These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 9013769)

  • 1. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.
    Masuyama H; Jefcoat SC; MacDonald PN
    Mol Endocrinol; 1997 Feb; 11(2):218-28. PubMed ID: 9013769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.
    Jurutka PW; Remus LS; Whitfield GK; Thompson PD; Hsieh JC; Zitzer H; Tavakkoli P; Galligan MA; Dang HT; Haussler CA; Haussler MR
    Mol Endocrinol; 2000 Mar; 14(3):401-20. PubMed ID: 10707958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin D receptor interacts with general transcription factor IIB.
    MacDonald PN; Sherman DR; Dowd DR; Jefcoat SC; DeLisle RK
    J Biol Chem; 1995 Mar; 270(9):4748-52. PubMed ID: 7876247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.
    Blanco JC; Wang IM; Tsai SY; Tsai MJ; O'Malley BW; Jurutka PW; Haussler MR; Ozato K
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1535-9. PubMed ID: 7878015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
    Raval-Pandya M; Dhawan P; Barletta F; Christakos S
    Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro.
    Jurutka PW; Hsieh JC; Remus LS; Whitfield GK; Thompson PD; Haussler CA; Blanco JC; Ozato K; Haussler MR
    J Biol Chem; 1997 Jun; 272(23):14592-9. PubMed ID: 9169418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1.
    Gill RK; Atkins LM; Hollis BW; Bell NH
    Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor.
    Swamy N; Mohr SC; Xu W; Ray R
    Arch Biochem Biophys; 1999 Mar; 363(2):219-26. PubMed ID: 10068443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.